Showing results (271-280 of 390) with videos related to

Sort By:
Pageof 39
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 29, 2018
Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depressionLucia Carboni, Luca Marchetti, Mario Lauria, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Laboratory Animals|October 3, 2019
Systematic analysis of severity in a widely used cognitive depression model for miceAnne S Mallien, Christine Häger, Rupert Palme, et al.
Anesthesiology|March 19, 2025
Inhibition of Endoplasmic Reticulum Oxidoreductin 1 Modulates Neuronal Excitability and Nociceptive Sensitivity in MiceAislinn D Maguire, Shawn M Lamothe, Muhammad Saad Yousuf, et al.
Science Signaling|September 19, 2019
Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cellsSarah Dimeloe, Patrick Gubser, Jordan Loeliger, et al.
Frontiers in Immunology|November 6, 2023
13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustionAlexander Kirchmair, Niloofar Nemati, Giorgia Lamberti, et al.
Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2008
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patientsAshley J Knights, Natko Nuber, Christopher W Thomson, et al.
Cellular & Molecular Immunology|March 6, 2024
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2Ronja Wieboldt, Michael Sandholzer, Emanuele Carlini, et al.
Plos One|March 12, 2024
SARS-CoV2 evokes structural brain changes resulting in declined executive functionDaniel Deuter, Katharina Hense, Kevin Kunkel, et al.
Pageof 39